Cerebral Phaeohyphomycosis in a Patient with Neurosarcoidosis on Chronic Steroid Therapy Secondary to Recreational Marijuana Usage
Figure 2
Axial (a) and coronal (b, c) T1-weighted fat suppressed images following administration of 15 mL intravenous gadolinium. There is diffuse enhancement within the skull base (green arrow), cavernous sinus (red arrow), internal auditory canal (blue arrow), prepontine cistern, and inferior extension of the enhancing lesion (white arrow) into the brainstem characteristic of granulomatous changes in neurosarcoidosis.
